Latest News

Monday, January 15, 2018

Ophthalmic Consultants of Long Island Expands Glen Cove Presence with New Office Move

Ophthalmic Consultants of Long Island has moved its Glen Cove office today. It is now in a larger, more modern facility with eight exam rooms with a focus on an exceptional patient experience and comp…

Read the full story

Monday, January 15, 2018

Combining Cataract Surgery, Baerveldt-tube Implant Sometimes Useful for Glaucoma

Cataract surgery and implantation of a Baerveldt tube (BT) for glaucoma should be done separately in most cases, but may be combined in some, research from Switzerland suggests, according to a Reuters…

Read the full story

Monday, January 15, 2018

Moorfields Eye Hospital Dubai Launches New Genetic Service for the UAE

Moorfields Eye Hospital Dubai has launched a new genetic service in the UAE to provide patients with genetic testing and enable access to the latest information on drug and gene therapy trials to trea…

Read the full story

Friday, January 12, 2018

Stephen H. Speares Named ASCRS Executive Director

The American Society of Cataract and Refractive Surgery’s (ASCRS) Executive Committee announced that Stephen H. Speares, an accomplished ophthalmology executive, will serve as the society’…

Read the full story

Friday, January 12, 2018

The Medical Affairs Professional Society (MAPS) taps Charlotte Kremer, MD, MBA as its next Global President

The Medical Affairs Professional Society (MAPS), the non-profit global society of Medical Affairs professionals, announces the appointment of Dr. Charlotte Kremer as its next Global President, effecti…

Read the full story

Friday, January 12, 2018

Wills Eye Hospital Reveals Ophthalmology Trends for 2018 and Beyond

A survey of ophthalmologists conducted by Wills Eye Hospital and Ocular Surgery News uncovered current realities and forward-looking trends in the field of ophthalmology. "The survey data conf…

Read the full story

Friday, January 12, 2018

More Kids Getting Eye Injuries From Paintball and Pellet Guns

A growing number of children are getting treated in U.S. emergency rooms for eye injuries from paintball or BB and pellet guns, a new study suggests, according to a report in Reuters. While team sp…

Read the full story

Thursday, January 11, 2018

Lensar Acquires Laser Business Assets of Precision Eye Services

Lensar announced the acquisition of the laser business unit of Bloomington, Minnesota-based Precision Eye Services (PES). This acquisition consolidates the company’s customer base for greater op…

Read the full story

Thursday, January 11, 2018

Low-dose Ranibizumab Effective for Retinopathy of Prematurity

Low doses of anti-VEGF therapy with ranibizumab are effective in infants with retinopathy of prematurity (ROP), according to results from the CARE-ROP study, as reported in Medscape. "The CARE…

Read the full story

Thursday, January 11, 2018

Latest Innovega Patent Allowance Is Awarded in Advance of Imminent Wearable Display Technology Boom

The US Patent and Trademark Office issued two notices of allowance to complement the 11 US patents already issued to Innovega, a Washington-based company that aims to deliver stylish, light-weight, we…

Read the full story

Wednesday, January 10, 2018

Sutter Health’s Palo Alto Medical Foundation and Plusoptix Collaborate to Improve Vision Screening for Kids

Palo Alto Medical Foundation, an affiliate of Sutter Health, a not-for-profit health care system in Northern California, and Plusoptix, a leader in instrument based vision screening, announced they ar…

Read the full story

Wednesday, January 10, 2018

GenSight Biologics Receives MHRA Approval to Initiate Phase 1/2 PIONEER Clinical Trial of Gene Therapy in Retinitis Pigmentosa

GenSight Biologics announced that the UK Medicines and Healthcare Regulatory Agency (MHRA) has accepted the company’s clinical trial application (CTA) to initiate the PIONEER phase 1/2 study of …

Read the full story

Wednesday, January 10, 2018

Glaukos' iDose Travoprost Achieves Sustained IOP Reduction and Favorable Safety Profile in 12-Month Interim Cohort

Glaukos announced that its travoprost Intraocular Implant with the iDose delivery system continued to provide sustained reduction in IOP in a 12-month interim cohort of patients in its U.S. investigat…

Read the full story

Wednesday, January 10, 2018

Don't Expect Restasis Generics Until At Least Next Quarter, Allergan CEO Says

Update on those Restasis generics Allergan investors have been seriously dreading: The company now believes they’re “unlikely” to arrive before the second quarter, CEO Brent Saunders…

Read the full story

Tuesday, January 09, 2018

Global Dry Eye Treatment Revenues to Grow to $4.9 Billion by 2022

Market Scope expects the global dry eye treatments market to grow at a healthy pace through 2022, as 2017 revenues of $3.7 billion climb to $4.9 billion. Revenues will climb most sharply in emerging m…

Read the full story
Load More
 Stock Price  Change 
 ADVM $3.98  0.00% 
 Aerie Pharmaceuticals, Inc. $58.63  -0.30% 
 Akorn, Inc. $33.56  -0.01% 
 Alimera Sciences, Inc. $1.27  -1.17% 
 Allergan $176.05  -0.60% 
 Applied Genetic Technologies $4.23  -1.74% 
 Bayer $31.03  -2.79% 
 Can-Fite Biopharma $1.87  2.75% 
 Carl Zeiss Meditec $46.04  -11.98% 
 Clearside Biomedical $6.36  2.25% 
 Cooper Companies, Inc. $230.79  0.94% 
 Eleven Biotherapeutics $0.86  -1.21% 
 Escalon Medical Corp. $0.18  5.88% 
 Essilor International $107.65  -4.06% 
 Glaukos $28.28  -0.98% 
 Imprimis Pharmaceuticals, Inc. $1.85  1.65% 
 Inotek Pharmaceuticals $3.03  -5.31% 
 Johnson & Johnson $145.78  0.68% 
 Merck & Company, Inc. $58.67  1.85% 
 NicOx $8.88  -13.79% 
 NovaBay Pharmaceuticals, Inc. $3.70  2.78% 
 Novartis AG Common Stock $86.63  1.12% 
 Ocular Therapeutix $5.63  14.66% 
 Ophthotech Corporation $2.87  2.69% 
 Quantel $6.40  -16.99% 
 Regeneron $366.79  -0.40% 
 Roche $32.03  2.10% 
 Second Sight Medical Products $2.03  1.25% 
 Shire $147.51  -0.61% 
 Spark Therapeutics, Inc. $52.67  -2.59% 
 STAAR Surgical Company $16.10  -0.31% 
 TearLab Corporation $0.69  65.78% 
 Thrombogenics $3.45  -13.01% 
 Valeant Pharmaceuticals $23.82  0.04% 
 Xoma $33.77  1.50%